<DOC>
	<DOCNO>NCT00413764</DOCNO>
	<brief_summary>Tibolone register treatment menopausal symptom . It , however , know effect tibolone postmenopausal woman diagnose sexual dysfunction . This important currently approve treatment libido problem postmenopausal woman . Therefore , primary aim study compare effect tibolone estrogen/progestogen skin patch postmenopausal woman diagnose sexual dysfunction .</brief_summary>
	<brief_title>Efficacy Tibolone Versus Transdermal E2/NETA Sexual Function Naturally Postmenopausal Women ( P06089 )</brief_title>
	<detailed_description />
	<mesh_term>Tibolone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Physically mentally healthy postmenopausal woman , &gt; =48 &lt; =68 year age , intact uterus . Women suffer decreased satisfactory sexual activity compare young age sexual problem consider cause relationship/partner problem . The decreased sexual functioning result sexually related personal distress confirm FSDS ( score =15 ) . An affirmative answer give follow question : ( ) In previous year find sexual activity satisfy ? ( b ) Has decline satisfaction sexual activity ? ( c ) Are satisfied partner friend ? All subject establish sexual relationship least 6 month duration prior screen . Women sexually active . Normal mammography within 6 month prior randomization . Body mass index &gt; 18 &lt; =32 kg/m2 . Voluntary write informed consent Any unexplained abnormal uterine bleeding Double layer endometrial thickness &gt; 4 mm Tibolone transdermal E2/NETA use within 3 month prior screen Progestogen implant injection estrogen/progestogen injectable therapy within 6 month prior screen Use intrauterine progestogen Unsuccessful previous treatment androgen compound known enhance androgenic activity Current successful treatment androgen , without apply applicable washout period 3 month prior screen Any previous current unopposed estrogen administration , prior use estrogen pellet tamoxifen citrate ( previous low dose vaginal estrogenonly application allow ) Use anti androgen within precede 5 year prior screen . Women significant organic disorder sexual dysfunction partner sexual dysfunction Women early onset sexual dysfunction ( &gt; 15 year prior menopause ) Women suffer androgenic alopecia , acne hirsutism Women suffer illness influence sexuality Women use medication influence sexuality Moderate severe depression Current prior use antidepressant within 8 week prior screen Major gynecological surgery precede 3 month Any serious disease disorder ; endocrine disorder systemic disease would impair overall health well ( control hypo/hyperthyroidism diabetes mellitus Type II allow ) History presence severe psychiatric illness and/or addiction drug , medication alcohol past 3 year Diseases exogenous hormonal steroid contraindicate . History presence malignancy , except successfully treat nonmelanoma skin cancer History presence cardiovascular cerebrovascular condition , thrombosis thromboembolic disorder History presence liver , gallbladder renal disease , epilepsy classical migraine headache Uncontrolled hypertension Women abnormal cervical smear result History presence breast cancer , suspicious breast lump mammographic abnormality Known hypersensitivity ingredient trial medication . Noncompliance screen diary Current use raloxifene , clonidine , veralipride , phytoestrogen extract Drugs know interfere pharmacokinetics steroid Use investigational drug within past 60 day Any disease condition clinically relevant , opinion investigator , would jeopardize subject 's well course trial</criteria>
	<gender>Female</gender>
	<minimum_age>48 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>